Vaccinex

Filed a patent for "combination therapy with semaphorin-4d blockade (sema4d) and dc1 therapy" on Thu, February 15, 2024

Filed a patent for "anti-ccr8 antibodies and uses thereof" on Thu, June 6, 2024

Filed a patent for "use of poxvirus display to select antibodies specific to complex membrane antigens" on Fri, June 10, 2022

Filed a patent for "predictive outcome profiling for use of an anti-semaphorin-4d binding molecule to treat neurodegenerative disorders" on Thu, March 30, 2023